EVH

insider transactions

Evolent Health, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 4, 26

Russell Monroe Glass

Director

$0

41.1K sh

Own +113%
Grant·A
Jun 4, 26

Peter J Grua

Director

$0

41.1K sh

Own +187%
Grant·A
Jun 4, 26

Shawn M Guertin

Director

$0

41.1K sh

Own +187%
Grant·A
Jun 4, 26

Richard M Jelinek

Director

$0

41.1K sh

Own +113%
Grant·A
Jun 4, 26

Kim Keck

Director

$0

41.1K sh

Own +67%
Grant·A
Jun 4, 26

Jill D. Smith

Director

$0

41.1K sh

Own +178%
Grant·A
Jun 4, 26

Brendan B Springstubb

Director

$0

41.1K sh

Own +70%
Grant·A
Jun 4, 26

Toyin Ajayi

Director

$0

41.1K sh

Own +121%
Other·F
Mar 3, 26

Jonathan Weinberg

General Counsel

$29.0K

8.3K sh · $3.51

Own -3%
Other·F
Mar 3, 26

Daniel Joseph Mccarthy KEY

PRESIDENT

$84.3K

24.0K sh · $3.51

Own -5%
Other·F
Mar 3, 26

Aammaad Shams

Chief Accounting Officer

$15.1K

4.3K sh · $3.51

Own -6%
Other·F
Mar 3, 26

Seth Blackley KEY

Chief Executive Officer

$84.4K

24.1K sh · $3.51

Own -3%
Grant·A
Mar 2, 26

Jonathan Weinberg

General Counsel

$0

179.7K sh

Own New
Other·F
Mar 2, 26

Jonathan Weinberg

General Counsel

$6.8K

1.9K sh · $3.58

Own -1%
Grant·A
Mar 2, 26

Jonathan Weinberg

General Counsel

$0

4.9K sh

Own +2%
Grant·A
Mar 2, 26

Daniel Joseph Mccarthy KEY

PRESIDENT

$0

826.4K sh

Own New
Other·F
Mar 2, 26

Daniel Joseph Mccarthy KEY

PRESIDENT

$65.1K

18.2K sh · $3.58

Own -4%
Grant·A
Mar 2, 26

Daniel Joseph Mccarthy KEY

PRESIDENT

$0

39.3K sh

Own +9%
Grant·A
Mar 2, 26

Aammaad Shams

Chief Accounting Officer

$0

55.2K sh

Own New
Other·F
Mar 2, 26

Aammaad Shams

Chief Accounting Officer

$3.0K

850 sh · $3.58

Own -1%
Grant·A
Mar 2, 26

Aammaad Shams

Chief Accounting Officer

$0

1.7K sh

Own +2%
Grant·A
Mar 2, 26

Mario Ramos KEY

Chief Financial Officer

$0

429.0K sh

Own New
Grant·A
Mar 2, 26

Seth Blackley KEY

Chief Executive Officer

$0

1.4M sh

Own New
Other·F
Mar 2, 26

Seth Blackley KEY

Chief Executive Officer

$63.5K

17.7K sh · $3.58

Own -2%
Grant·A
Mar 2, 26

Seth Blackley KEY

Chief Executive Officer

$0

58.9K sh

Own +7%
Other·F
Mar 1, 26

Jonathan Weinberg

General Counsel

$14.3K

4.4K sh · $3.25

Own -2%
Other·F
Mar 1, 26

Daniel Joseph Mccarthy KEY

PRESIDENT

$25.4K

7.8K sh · $3.25

Own -2%
Other·F
Mar 1, 26

Aammaad Shams

Chief Accounting Officer

$8.4K

2.6K sh · $3.25

Own -4%
Other·F
Mar 1, 26

Seth Blackley KEY

Chief Executive Officer

$31.0K

9.5K sh · $3.25

Own -1%
Grant·A
Jan 2, 26

Mario Ramos KEY

Chief Financial Officer

$0

587.5K sh

Own New
Grant·A
Jan 2, 26

Jill D. Smith

Director

$0

23.1K sh

Own New

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 4, 2026	Russell Monroe Glass	Director	Grant A	41.1K	+113%	—	$0
Jun 4, 2026	Peter J Grua	Director	Grant A	41.1K	+187%	—	$0
Jun 4, 2026	Shawn M Guertin	Director	Grant A	41.1K	+187%	—	$0
Jun 4, 2026	Richard M Jelinek	Director	Grant A	41.1K	+113%	—	$0
Jun 4, 2026	Kim Keck	Director	Grant A	41.1K	+67%	—	$0
Jun 4, 2026	Jill D. Smith	Director	Grant A	41.1K	+178%	—	$0
Jun 4, 2026	Brendan B Springstubb	Director	Grant A	41.1K	+70%	—	$0
Jun 4, 2026	Toyin Ajayi	Director	Grant A	41.1K	+121%	—	$0
Mar 3, 2026	Jonathan Weinberg	General Counsel	Other F	8.3K	-3%	$3.51	$29.0K
Mar 3, 2026	Daniel Joseph Mccarthy KEY	PRESIDENT	Other F	24.0K	-5%	$3.51	$84.3K
Mar 3, 2026	Aammaad Shams	Chief Accounting Officer	Other F	4.3K	-6%	$3.51	$15.1K
Mar 3, 2026	Seth Blackley KEY	Chief Executive Officer	Other F	24.1K	-3%	$3.51	$84.4K
Mar 2, 2026	Jonathan Weinberg	General Counsel	Grant A	179.7K	New	—	$0
Mar 2, 2026	Jonathan Weinberg	General Counsel	Other F	1.9K	-1%	$3.58	$6.8K
Mar 2, 2026	Jonathan Weinberg	General Counsel	Grant A	4.9K	+2%	—	$0
Mar 2, 2026	Daniel Joseph Mccarthy KEY	PRESIDENT	Grant A	826.4K	New	—	$0
Mar 2, 2026	Daniel Joseph Mccarthy KEY	PRESIDENT	Other F	18.2K	-4%	$3.58	$65.1K
Mar 2, 2026	Daniel Joseph Mccarthy KEY	PRESIDENT	Grant A	39.3K	+9%	—	$0
Mar 2, 2026	Aammaad Shams	Chief Accounting Officer	Grant A	55.2K	New	—	$0
Mar 2, 2026	Aammaad Shams	Chief Accounting Officer	Other F	850	-1%	$3.58	$3.0K
Mar 2, 2026	Aammaad Shams	Chief Accounting Officer	Grant A	1.7K	+2%	—	$0
Mar 2, 2026	Mario Ramos KEY	Chief Financial Officer	Grant A	429.0K	New	—	$0
Mar 2, 2026	Seth Blackley KEY	Chief Executive Officer	Grant A	1.4M	New	—	$0
Mar 2, 2026	Seth Blackley KEY	Chief Executive Officer	Other F	17.7K	-2%	$3.58	$63.5K
Mar 2, 2026	Seth Blackley KEY	Chief Executive Officer	Grant A	58.9K	+7%	—	$0
Mar 1, 2026	Jonathan Weinberg	General Counsel	Other F	4.4K	-2%	$3.25	$14.3K
Mar 1, 2026	Daniel Joseph Mccarthy KEY	PRESIDENT	Other F	7.8K	-2%	$3.25	$25.4K
Mar 1, 2026	Aammaad Shams	Chief Accounting Officer	Other F	2.6K	-4%	$3.25	$8.4K
Mar 1, 2026	Seth Blackley KEY	Chief Executive Officer	Other F	9.5K	-1%	$3.25	$31.0K
Jan 2, 2026	Mario Ramos KEY	Chief Financial Officer	Grant A	587.5K	New	—	$0
Jan 2, 2026	Jill D. Smith	Director	Grant A	23.1K	New	—	$0

About EVH insider trading

This page tracks insider transactions for Evolent Health, Inc. (EVH) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.